Routine Health Screening Market

Report Code: HLC299A

Publish Date: Jul 2024

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $5500

Member Price: FREE

Use code SUMMER at checkout for 50% OFF

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.

Report Includes

  • 37 data tables and 39 additional tables
  • An overview of the global market for routine health screening
  • Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
  • Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by test type, sample type, technology, and region
  • A look at recent innovations, technological advances, and product launches in the market
  • Analysis of the industry’s regulatory framework and policies
  • A discussion of ESG challenges and practices in the routine health screening industry
  • An analysis of the key companies’ market shares, proprietary technologies, alliances, and other strategies
  • A discussion of key patents
  • Profiles of the leading players, including Quest Diagnostics, Laboratory Corporation of America Holdings, Sonic Healthcare Ltd., Eurofins Scientific, and SYNLAB AG

Report Scope

The routine health screening market presents a vast and promising opportunity as it responds to evolving healthcare trends and societal needs. With an increasing emphasis on preventive healthcare, routine health screenings have become instrumental in detecting potential health issues at early stages. The market’s expansion is propelled by the rising incidence of non-communicable diseases, such as diabetes and cardiovascular disorders, coupled with the aging global population, necessitating proactive health management strategies. Technological advancements, including innovations in diagnostic tools and the integration of artificial intelligence, enhance the accuracy and accessibility of screenings, catering to a broader demographic. The aftermath of the COVID-19 pandemic has further underscored the importance of regular health check-ups, reinforcing the significance of routine health screenings.

Additionally, incorporating these screenings into corporate wellness programs and the trend toward personalized medicine further amplifies the market’s potential. The routine health screening market is poised for substantial expansion, playing a pivotal role in the proactive and personalized management of individual health globally. This report presents insights into this market’s current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges, and strategies (e.g., mergers, acquisitions, collaborations). The report informs all market players, potential entrants, government agencies, and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $56.6 billion
Market size forecast $82.9 billion
Growth rate CAGR of 6.8% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered Test Type, Sample Type, Technology, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Middle East and Africa
Key Market Drivers
  • Growing prevalence of chronic diseases.
  • Growing health consciousness.
  • Advancements in screening technology.
Companies studied
ARUP LABORATORIESCERBA HEALTHCARE
EUROFINS SCIENTIFICEXACT SCIENCE CORP.
OPKO HEALTH INC.LABORATORY CORPORATION OF AMERICA HOLDINGS
NATERA INC.QUEST DIAGNOSTICS INC.
SONIC HEALTHCARE LTD.SYNLAB AG
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The Global routine health screening market is projected to grow from $56.6 billion in 2023 to $82.9 billion in 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period.
  • Increase prevalence of chronic diseases.
  • Increase in health awareness.
  • Advancements in technology.
This report segments the market based on type, technology, sample, and region. The market is segmented based on the type into Cholesterol Screening, Diabetes Screening, Blood Pressure Tests, Cancer Screening, Prenatal screening, Vision and Hearing Screenings, Bone Density Tests, Thyroid Profile Tests, Essential Nutrients Tests, and Others. The market is segmented based on technology into QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), Immunoassays, Medical Imaging, STELA (Single Telomere Length Analysis), and Others. The market is segmented into blood, urine, saliva, imaging samples, and others based on application. Based on region, the market is segmented into North America, Europe, Asia-Pacific, and the rest of the world.
Diabetes will dominate the market by the end of 2029.
North America holds the highest share in the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Christian Goodwin, MD, MPH, is a resident physician at Duke University. He completed his undergraduate degree at the University of Virginia. He obtained his MPH at the University of Liverpool as a US-UK Fulbright Scholar while serving as a visiting researcher at the Palliative Care Institute Liverpool. He obtained his MD from the University of North Carolina as a Blanchard Scholar. Christian has expertise in health systems innovation, public health research, geriatrics, and psychiatry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Routine Health Screening Market136Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview5Free
Chapter- 3: Market Dynamics11Free
Chapter- 4: Market Segmentation Analysis53Free
Chapter- 5: Emerging and Upcoming Technologies in the Market6Free
Chapter- 6: ESG Development5Free
Chapter- 7: Competitive Landscape5Free
Chapter- 8: Appendix46Free

Related Reports

Fetal Monitoring, Diagnostics and Predictive Tests

Published - Apr 2023 | Publisher - BCC Publishing | Code - HLC089C

The global market for fetal monitoring, diagnostics and predictive tests is estimated to increase from $10.4 billion in 2022 to reach $13.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.

AI in Diabetes Management: Global Market Outlook

Published - Apr 2023 | Publisher - BCC Publishing | Code - IFT273A

This report presents an in-depth assessment of the global market outlook for artificial intelligence (AI) in diabetes management. The study includes AI in diabetes management care platforms and associated services. It covers the impact of macroeconomic factors affecting the global market for AI in diabetes management. The report examines emerging market trends, and underlying future opportunities in the market. The report concludes with the company profiles of leading market participants and their offerings in AI in diabetes management products, solutions and services.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Apr 2022 | Publisher - BCC Publishing | Code - HLC239B

The global market for chronic disease management therapeutics anddevice technologies should grow from $391.8 billion in 2021 to $553.0 billion by 2026, at compound annual growth rate (CAGR) of 7.1% for the period of 2021-2026.

Breast Cancer Diagnostic and Drug Technologies: Global Markets

Published - Dec 2019 | Publisher - BCC Publishing | Code - HLC106D

The global breast cancer diagnostic and drug market should reach $28.2 billion by 2024 from $20.9 billion in 2019 at a compound annual growth rate (CAGR) of 6.2% for the forecast period of 2019 to 2024.

Recent Reports

Wearable Medical Devices: Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC192D

The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC176E

The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.

Routine Health Screening Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC299A

The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.

Elder Care Services and Assistive Devices: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC062E

The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.

Direct-to-Consumer Testing Industry: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC269B

The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Hydrogen Storage: Materials, Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - EGY146C

The global market for hydrogen storage materials and technologies is expected to grow from $5.3 billion in 2023 to $7.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Solid State Batteries: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - FCB053B

The global market for solid state batteries is estimated to increase from $274.0 million in 2023 to reach $1.7 billion by 2029, at a compound annual growth rate (CAGR) of 36.7% from 2024 through 2029.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Life Science Tools and Reagents: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Routine Health Screening Market
Sample Report